Browse by author
Lookup NU author(s): Sandra Robinson, Dr David Walker
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Objectives. Following the recent National Institute for Health and Clinical Excellence guidance on the management of RA, we were interested to see if we could negotiate targets for treatment with patients in routine clinics, how they would express this and whether staying at work would be a target. Methods. One hundred RA patients were recruited. They were consecutive within clinics, but not all clinics were used. They were asked their understanding of the DAS score and a target for treatment negotiated. Any impact of the RA on their paid employment was then explored. Results. Four participants were unable to specify a target for their RA. Negotiated targets were expressed as restricted activities and either as maintaining an activity (70) if the disease was stable, or regaining an activity (26) if the treatment was being increased. Targets were walking a distance for 50% of patients; leisure activities for 18%; domestic activities for 17%; work for 14% and personal care for 2%. For the 21 participants currently working, maintaining work was the target for 12, with 1 wishing to regain lost hours. No patient currently not working expressed returning to work as a target. There were some differences in targets between men and women. Conclusions. Patients are able to negotiate a target for their treatment, expressed as maintaining or regaining a physical activity. Work ceases to be a target once it is lost. Therefore, preventing loss of occupation is likely to be more effective than trying to regain it.
Author(s): Robinson SM, Walker DJ
Publication type: Article
Publication status: Published
Journal: Rheumatology
Year: 2012
Volume: 51
Issue: 2
Pages: 293-296
Print publication date: 25/08/2011
ISSN (print): 1462-0324
ISSN (electronic): 1462-0332
Publisher: Oxford University Press
URL: http://dx.doi.org/10.1093/rheumatology/ker237
DOI: 10.1093/rheumatology/ker237
Altmetrics provided by Altmetric
